When the first cryo-electron microscope images came through, the team at POSTECH saw something never before made by human hands: a perfectly spherical, hollow protein shell, 220 nanometers wide, assembled entirely from a single AI-designed protein—no virus, no genetic template, just precision-engineered biology. Led by Professor Sangmin Lee of Pohang University of Science and Technology and Nobel laureate Professor David Baker of the University of Washington, the international collaboration has cracked a decades-old challenge in structural biology: how to mimic the elegant quasisymmetry of natural viruses using artificial proteins. The breakthrough, published in Nature, opens a new frontier in biomedicine, where nature’s design principles are no longer copied—but recreated from scratch.
Viruses have long fascinated scientists for their ability to self-assemble massive, stable shells from hundreds of identical protein units, subtly adjusting their positions to form near-spherical structures—a phenomenon known as quasisymmetry. This delicate balance of geometry allows them to enclose large genomes efficiently. But replicating this in synthetic systems has been nearly impossible, limited by the rigidity of traditional symmetric designs. Most artificial protein nanocages to date have been small and uniform, capped at around 70 nanometers, because they rely on perfectly repeating units that can’t adapt to curvature. The POSTECH team changed that by rethinking the building block itself.
Instead of forcing symmetry, they used a trimeric unit—three proteins linked together—and applied RFdiffusion, an AI-powered protein design tool, to engineer flexible connectors that allow the same protein to fit into both pentagonal and hexagonal arrangements depending on its position. Like interlocking tiles on a geodesic dome, these proteins automatically adjust their angles during assembly, enabling the formation of much larger, variable-sized shells. The result? Self-assembling nanocages ranging from 70 to 220 nanometers in diameter—some over three times larger than previous designs—all formed from a single, AI-generated protein component.
Using E. coli to produce the proteins, the researchers confirmed successful assembly through cryo-electron microscopy, revealing intricate spherical structures that closely matched computational models. The smallest resembled a nano-scale soccer ball, while the largest approached the size of some natural viruses. This scalability is key: larger cages mean more cargo capacity—whether that’s mRNA, cancer drugs, or vaccine antigens—delivered with precision and stability.
The implications are profound. Unlike existing delivery systems that repurpose viral shells, this technology builds from the ground up, offering full control over size, shape, and function. Future work will focus on refining uniformity using internal scaffolds, but the foundation is now set. For vaccine development and targeted therapies, this could mean customizable, non-immunogenic carriers tailored to specific diseases. In a world where delivery is often the bottleneck in medicine, this AI-designed shell may become one of the most important vessels in biotechnology.